Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
3/25/25 Axsome Therapeutics (AXSM) Sunosi for Attention Deficit Hyperactivity Disorder (ADHD) Subscribers Only Subscribers Only Subscribers Only
3/19/25 Immunovant (IMVT) Batoclimab for Myasthenia Gravis (MG) Subscribers Only Subscribers Only Subscribers Only
3/17/25 ORCA Bio Orca-T for Myelodysplastic Syndrome (MDS) Subscribers Only Subscribers Only Subscribers Only
3/17/25 ORCA Bio Orca-T for Acute Lymphoblastic Leukemia (ALL) Subscribers Only Subscribers Only Subscribers Only
3/17/25 ORCA Bio Orca-T for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
12/31/2024 Subscribers Only Subscribers Only Regulatory - IND/CTA Filing
02/12/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
02/27/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
03/24/2025 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
03/25/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation